FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Pine Pharmaceuticals, LLC(079432784)" | 6-6-Dideuteroglucose | 72.9 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-948 | 69194-948-01 | Epinephrine; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-886 | 69194-886-01 | Fentanyl Citrate | 10 ug/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-135 | 69194-135-01 | Foscarnet Sodium | 2.4 mg/.1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Glycerin | 11.7 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-887 | 69194-887-01 | Ketamine Hydrochloride | 2.5 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 40 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-802 | 69194-802-01 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Atorvastatin Calcium Trihydrate | 40 mg | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-129 | 69194-129-01 | Moxifloxacin Hydrochloride | 100 ug/.1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-130 | 69194-130-01 | Moxifloxacin Hydrochloride | 150 ug/.1 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 32 mg/250 mL | 2026-1 | valid | 2026-10-06 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-978 | 69194-978-10 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(036662848)" | Potassium Chloride; Magnesium Sulfate Heptahydrate; Lidocaine | 1.94 g/1052.8 mL; 2 g/1052.8 mL; .13 g/1052.8 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine Hydrochloride | 6000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 140 mg/7 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 200 mg/10 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 500 g/5000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 300000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2000 mg/20 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 3 g/100 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 1000 mg/10 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2 g/100 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 300000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Dextrose Monohydrate | 1500000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Dextrose Monohydrate | 25000 mg/50 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Diltiazem Hydrochloride | 15000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Hydrochloride | 30000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Hydrochloride | 15000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 25 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/5 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 150000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/10 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl | 30000 ug/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2500 ug/250 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 1000 ug/100 mL | 2026-1 | source_no_ndc | 2026-10-06 |